PCRX SG&A Expense Growth
Pacira Biosciences Inc · SG&A Expense Growth
PCRX SG&A Expense Growth
Latest reported25.39%period ending
PCRX FY SG&A Growth (YoY) (0.00% → 25.39%)
Latest values, visible window
High-resolution chart · PNG
PCRX sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 25.386% | |
| 9.1515% | |
| 5.8641% | |
| 27.6761% | |
| 3.0122% | |
| -3.6189% | |
| 13.2666% | |
| 9.7657% | |
| 5.8193% | |
| 9.7596% | |
| 30.3585% | |
| 70.6374% | |
| 34.989% | |
| 129.7039% | |
| 234.3118% | |
| 20.1195% | |
| -41.7025% | |
| 0% |